ARKO
Arko Corp.
ARKO trails on the overall score without a compensating advantage in the available component scores.
LCID
Lucid Group, Inc.
LCID has the edge over ARKO overall, supported by stronger valuation and stronger modeled upside.
ARKO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Healthy |
ARKO's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ARKO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $0.99 | -76% |
| Fair | 28x | $1.70 | -59% |
| Forward | 29x | $4.10 | — |
| Expensive | 62x | $3.70 | -9.9% |
| Current | 68x | $4.10 | — |
Historical ranges are pointers, not guarantees.
ARKO's PE is in its expensive range at 68x. If earnings grow as analysts expect, today's price would be 29x next year's earnings, in its fair range.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ARKO Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect ARKO's earnings to grow, with its revenue and profitability holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ARKO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.14 | +133% |
| Q3 2026 | $0.06 | -45% |
| Q2 2026 | $0.08 | 0% |
| Q1 2026 | $0.20 | +567% |
| Q4 2025 | $0.15 | +15% |
| Q3 2025 | $0.11 | -27% |
| Q2 2025 | $0.08 | -68% |
| Q1 2025 | $0.03 | -88% |
| Q4 2024 | $0.13 | -46% |
ARKO has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ARKO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.4B | +18% |
| Q2 2026 | $2.3B | +17% |
| Q1 2026 | $1.8B | -3.1% |
| Q4 2025 | $1.8B | -9.9% |
| Q3 2025 | $2B | -11% |
| Q2 2025 | $2B | -16% |
| Q1 2025 | $1.8B | -12% |
| Q4 2024 | $2B | -11% |
ARKO's revenue is growing: $2.4B last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | -0.3 points |
| Q2 2026 | 1.3% | -1.5 points |
| Q1 2026 | 0.6% | +1.2 points |
| Q4 2025 | 1.2% | +0.5 points |
| Q3 2025 | 1.8% | 0 points |
| Q2 2025 | 2.8% | +1 points |
| Q1 2025 | -0.6% | -0.4 points |
| Q4 2024 | 0.7% | -0.4 points |
ARKO has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over ARKO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
ARKO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.5M | -147% |
| Q2 2026 | $8.9M | -9.5% |
| Q1 2026 | -$11.6M | -173% |
| Q4 2025 | $14.9M | +$28.3M |
| Q3 2025 | $24.5M | -69% |
| Q2 2025 | $9.8M | -83% |
| Q1 2025 | $16M | +$32.5M |
| Q4 2024 | -$13.4M | -162% |
ARKO has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ARKO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -36K shares |
| 1 year | +0.6% | +644K shares |
| 3 years | -3.7% | -4.4M shares |
| 5 years | -13% | -18.1M shares |
| Available history | -74% | -326M shares |
ARKO has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $51,000 |
| Q2 2026 | $212,000 |
| Q1 2026 | $4.3M |
| Q4 2025 | $7.2M |
| Q3 2025 | $4.2M |
| Q2 2025 | $9.2M |
| Q1 2025 | $7.4M |
| Q4 2024 | — |
ARKO spent $12M buying back its own shares over the past year, down 43% from the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
ARKO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 1.9x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 2.6x | Moderate |
| Q2 2025 | 2.6x | Moderate |
| Q1 2025 | 2.8x | Moderate |
| Q4 2024 | 2.7x | Moderate |
ARKO's net debt is about 1.9 years of its operating earnings (EBITDA), down from 2.6 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ARKO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.4 | Neutral |
| Stochastic | 12.4 | Oversold |
ARKO's weekly RSI is 36 (neutral) and its Stochastic is 12 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ARKO PE vs Consumer Cyclical Sector
| Metric | ARKO | Sector median | Relative |
|---|---|---|---|
| PE | 68x | 18x | 279% above |
| PE % | 85 | 47 | 38 pts above |
ARKO is trading at 68x earnings, a 279% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ARKO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.04 | 1.5% above |
| 20 week MA | $5.28 | 22% below |
| 50 week MA | $5.78 | 29% below |
| 100 week MA | $5.35 | 23% below |
| 200 week MA | $6.27 | 35% below |
ARKO has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ARKO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.0 | $9.44 | -5.9% |
| 2021 | $9.44 | $8.52 | -9.7% |
| 2022 | $8.52 | $8.62 | +1.2% |
| 2023 | $8.62 | $8.25 | -4.3% |
| 2024 | $8.25 | $6.53 | -21% |
| 2025 | $6.53 | $4.64 | -29% |
| 2026 YTD | $4.64 | $4.10 | -12% |
ARKO has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.